MichaelChuongMDFACRO

PubMed

• 45 citations
  Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
  Ravi Shridhar, Sarah E. Hoffe, Khaldoun Almhanna, Jill Weber, Michael D. Chuong
  Annals of Surgical Oncology. 2013-04-28
• 115 citations
  Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Ra...
  Matthew H G Katz, Qian Shi, Jeff Meyers, Joseph M Herman, Michael Chuong
  JAMA Oncology. 2022-09-01
• 19 citations
  Minimal acute toxicity from proton beam therapy for major salivary gland cancer.
  Michael D. Chuong, John Bryant, William F. Hartsell, G.L. Larson, Shahed N. Badiyan
  Acta Oncologica. 2020-02-01

Journal Articles

• Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma  
  Mellon E, Hoffe S, Springett G, Frakes J, Hodul P, Malafa M, Strom T, Chuong M, Shridhar R, Acta Oncologica, 1/3/2015
• Anterior-oriented beam arrangements with daily in vivo range verification for proton therapy in prostate cancer: Rectal toxicity rates  
  Polf JC, Chuong MD, Zhang B, Mehta M, International Journal of Particle Therapy, 1/1/2015
• Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esopha...  
  Hyder J, Boggs D, Hanna A, Suntharalingam M, Chuong MD, Journal of Gastrointestinal Oncology, 1/1/2015
• Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer  
  Chuong MD, Frakes JM, Figura N, Hoffe SE, Shridhar R, Mellon EA, Hodul RJ, Malafa MP, Springett GM, Centeno BA, Journal of Gastrointestinal Oncology, 1/1/2015
• Selective internal radiation therapy for the treatment of inoperable neuroendocrine tumor liver metastases  
  Mohammadi H, Chuong MD, Sharma NK, International Journal of Endocrine Oncology, 1/1/2015
• Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy  
  D'Emic N, Engelman A, Molitoris J, Hanlon A, Sharma NK, Moeslein FM, Chuong MD, Journal of Gastrointestinal Oncology, 1/1/2015
• State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment  
  Lin J, Kligerman S, Goel R, Sajedi P, Suntharalingam M, Chuong MD, Journal of Gastrointestinal Oncology, 1/2/2014
• Adjuvant chemoradiation for pancreatic cancer: What does the evidence tell us?  
  Chuong MD, Boggs DH, Patel KN, Regine W, Journal of Gastrointestinal Oncology, 1/1/2014
• Lymph Node Harvest in Esophageal Cancer After Neoadjuvant Chemoradiotherapy  
  Shridhar R, Hoffe SE, Almhanna K, Weber JM, Chuong MD, Karl RC, Meredith K, Annals of Surgical Oncology, 1/28/2013
• HDR Endorectal Brachytherapy for Locally Advanced Rectal Cancer in Previously Irradiated Patients  
  Chuong MD, Fernandez DF, Shridhar R, Hoffe SE, Saini A, Hunt D, Meredith KL, Biagioli MC, Brachytherapy, 1/23/2013
• Increased Survival Associated with Surgery and Radiation Therapy in Metastatic Gastric Cancer: A SEER Database Analysis  
  Shridhar R, Almhanna K, Hoffe SE, Fulp W, Weber J, Chuong MD, Meredith KL, Cancer, 1/1/2013
• The Impact of the Size of Nodal Metastases on Recurrence Risk in Breast Cancer Patients with One to Three Positive Nodes Post-mastectomy  
  Harris ER, Freilich J, Lin H, Chuong M, Acs, International Journal of Radiation Oncology Biology Physics, 1/1/2013
• Intensity-Moduled Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal  
  Chuong MD, Freilich JM, Weber JM, Almhanna K, Meredith KL, Biagioli MC, Hoffe SE, Shridhar R, Gastrointestinal Cancer Research, 1/1/2013
• Stereotactic Body Radiation Therapy (SBRT) For Borderline Resectable and Locally Advanced Pancreatic Cancer Is Effective And Well-Tolerated  
  Chuong MD, Springett GM, Freilich JM, Park CK, Weber JM, Mellon EA, Hodul PJ, Malafa MP, Meredith KL, Hoffe SE, Shridhar R, International Journal of Radiation Oncology Biology Physics, 1/1/2013
• What is the role of radiation therapy in treating liver tumors?  
  Cruz A, Chuong MD, Shridhar R, Hoffe SE, Clinical Practice, 1/1/2012
• Induction gemcitabine-based chemotherapy and neoadjuvant stereotactic body radiation therapy achieve high margin-negative resection rates for borderline-resectable pan...  
  Chuong MD, Springett GM, Weber JM, Klapman J, Vignesh S, Hodul PJ, Malafa MP, Leuthold S, Hoffe SE, Shridhar R, Journal of Radiation Oncology, 1/1/2012
• Outcomes of anal cancer treated with definitive IMRT-based chemoradiation  
  Chuong MD, Hoffe SE, Weber J, Freilich JM, Lomas H, Almhanna K, Dessureault S, Dinwoodie W, Kim R, Meredith K, Strosberg J, Shibata D, Rao NG, Biagioli MC, Shridhar R, Journal of Radiation Oncology, 1/1/2012
• Body Mass Index and Survival in Esophageal Adenocarcinoma Treated with Chemoradiotherapy Followed by Esophagectomy  
  Shridhar R, Hayman T, Hoffe SE, Weber J, Almhanna K, Chuong M, Karl RC, Meredith KL, Journal of Gastrointestinal Surgery, 1/1/2012
• Effect of Prophylactic Fluconazole on Oral Mucositis and Cadidiasis During Radiotherapy for Head and Neck Cancer  
  Rao NG, Han G, Greene JN, Tanvetyanon T, Kish JA, DeConti RC, Shridhar R, Biagioli MC, Chuong MD, Caudell JJ, Trotti A, Practical Radiation Oncology, 1/1/2012
• Post Chemoradiation PET SUV is Highly Predictive of Overall Survival in Esophageal Cancer  
  Lomas H, Hoffe SE, Weber J, Dilling TJ, Chuong MD, Almhanna MD, Meredith KL, Shridhar R, Journal of Nuclear Medicine and Radiation Therapy, 1/1/2012
• Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer  
  Chuong MD, Hayman TJ, Patel M, Russell MS, Malafa MP, Hodul PJ, Springett GM, Choi J, Shridhar R, Hoffe SE, Gastrointestinal Cancer Research, 1/1/2011
• Join now to see all

Books/Book Chapters

• Essentials and Updates in Urologic Oncology 
  Chapter: Adrenal Cancer 
  Carter WB, Deneve JL, Tourtelot JD, Caricciolo J, Hoffe SE, Chuong MD, Lilienfeld HSNova Publishing2012
• Essentials and Updates in Urologic Oncology 
  Chapter: Radiotherapy Preservation Strategies for Bladder Center 
  Wilder RB, Biagioli MC, Sexton WJ, Fishman MN, Chuong MDNova Publishing2012

Lectures

• Gastrointestinal Cancers 
  Baltimore, MD - 1/8/2015
• Hepatocellular carcinoma and pancreatic cancer 
  UMMC, 2014, 2015 - 1/1/2015
• Is pencil beam scanning dosimetrically advantageous compared to passively scattered proton therapy for unresectable pancreatic cancer? 
  San Diego, CA - 1/1/2015
• A multi-institutional analysis of acute toxicity after neoadjuvant chemoradiation using photons or protons in trimodality esophageal cancer patients. 
  San Diego, CA - 1/1/2015
• Proton Therapy: Increasing the therapeutic ratio 
  UMMC - 1/30/2014
• Hepatocellular carcinoma 
  UMMC - 1/1/2013
• Stereotactic Body Radiation Therapy (SBRT) For Borderline Resectable and Locally Advanced Pancreatic Cancer is Effective and Well-Tolerated. 
  Boston, MA - 1/1/2012
• Stereotactic Body Radiation Therapy (SBRT) Results in High Rates of Margin-Negative Resection for Borderline Resectable Pancreatic Cancer. 
  Sarasota, FL - 1/1/2012
• Preoperative concomitant chemotherapy/EBRT with HDR brachytherapy boost for rectal adenocarcinoma: the initial Moffitt Cancer Center Experience. 
  San Diego, CA - 1/1/2011
• Preoperative HDR brachytherapy for rectal adenocarcinoma in previously irradiated patients: the initial Moffitt Cancer Center Experience. 
  San Diego, CA - 1/1/2011
• Join now to see all

Other

• Challenging Liver Cases (debate panel member) 
  Chuong MD, Particle Therapy Co-Operative Group Annual Meeting
  San Diego, CA - 1/1/2015